Salmonella enterica serovar Typhi strain producing extended-spectrum β-lactamases in Dhaka, Bangladesh

References

1. Ahmed D., D’Costa L. T., Alam K., Nair G. B., Hossain M. A. 2006; Multidrug-resistant Salmonella enterica serovar Typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh. Antimicrob Agents Chemother 50:3516–3517 [View Article][PubMed]
   [Google Scholar]
2. Al Naiemi N., Zwart B., Rijnsburger M. C., Roosendaal R., Debets-Ossenkopp Y. J., Mulder J. A., Fijen C. A., Maten W., Vandenbroucke-Grauls C. M., Savelkoul P. H. 2008; Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines. J Clin Microbiol 46:2794–2795 [View Article][PubMed]
   [Google Scholar]
3. Baraniak A., Sadowy E., Hryniewicz W., Gniadkowski M. 2002; Two different extended-spectrum β-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland. J Clin Microbiol 40:1095–1097 [View Article][PubMed]
   [Google Scholar]
4. Bavdekar S. B. 1996; Antimicrobial therapy of multidrug resistant typhoid fever in children: pediatricians’ opinion. J Postgrad Med 42:65–67[PubMed]
   [Google Scholar]
5. Cantón R., Novais A., Valverde A., Machado E., Peixe L., Baquero F., Coque T. M. 2008; Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14:Suppl. 1144–153 [View Article][PubMed]
   [Google Scholar]
6. CLSI 2008; Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement. M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute;
7. Crump J. A., Luby S. P., Mintz E. D. 2004; The global burden of typhoid fever. Bull World Health Organ 82:346–353[PubMed]
   [Google Scholar]
8. Edelstein M., Pimkin M., Palagin I., Edelstein I., Stratchounski L. 2003; Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 47:3724–3732 [View Article][PubMed]
   [Google Scholar]
9. Gniadkowski M. 2001; Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect 7:597–608 [View Article][PubMed]
   [Google Scholar]
10. Lal P., Kapil A., Das B. K., Sood S. 2007; Occurrence of TEM & SHV gene in extended spectrum beta-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J Med Res 125:173–178[PubMed]
    [Google Scholar]
11. Livermore D. M., Brown D. F. 2001; Detection of β-lactamase-mediated resistance. J Antimicrob Chemother 48:Suppl. 159–64 [View Article][PubMed]
    [Google Scholar]
12. Pardos de la Gándara M., Seral C., Castillo García J., Rubio Calvo C., Weill F. X. 2011; Prevalence and characterization of extended-spectrum beta-lactamases-producing Salmonella enterica isolates in Saragossa, Spain (2001–2008). Microb Drug Resist 17:207–213 [View Article][PubMed]
    [Google Scholar]
13. Pokharel B. M., Koirala J., Dahal R. K., Mishra S. K., Khadga P. K., Tuladhar N. R. 2006; Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Int J Infect Dis 10:434–438 [View Article][PubMed]
    [Google Scholar]
14. Saha S. K., Talukder S. Y., Islam M., Saha S. 1999; A highly ceftriaxone-resistant Salmonella Typhi in Bangladesh. Pediatr Infect Dis J 18:387 [View Article][PubMed]
    [Google Scholar]
15. Stephen J. M., Toleman M. A., Walsh T. R., Jones R. N. 2003; Salmonella bloodstream infections: report from the SENTRY Antimicrobial Surveillance Program (1997–2001). Int J Antimicrob Agents 22:395–405 [View Article][PubMed]
    [Google Scholar]
16. Threlfall E. J. 2002; Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol Rev 26:141–148 [View Article][PubMed]
    [Google Scholar]